References
Fuchs PC, Barry AL, Pfaller MA, et al. Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates. Antimicrob Agents Chemother 1991; 35 (4): 764–6
Jones RN, Johnson DM. Modification for disk diffusion susceptibility testing criteria of CLF (CI-960, AM-1091, CP127371) and fleroxacin (RO 23-6240, AM-833) following studies with a challenge-panel of ciprofloxacin-resistant clinical isolates. Diagn Microbiol Infect Dis. In press
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tack, K.J., McGuire, N.M. & Eiseman, I.A. Initial Clinical Experience with Clinafloxacin in the Treatment of Serious Infections. Drugs 49 (Suppl 2), 488–491 (1995). https://doi.org/10.2165/00003495-199500492-00145
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199500492-00145